# Scansource, Inc.: financial statements, quarterly SCSC · Nasdaq · CIK 918965 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/scsc.md) · [Financials](/companies/scsc/financials.md) · [Filings](/companies/scsc/filings.md) · [Insiders](/companies/scsc/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/scsc/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [876](/filings/0000918965-24-000040.md) | [885](/filings/0000918965-25-000010.md) | [753](/filings/0000918965-25-000018.md) | [746 d](/filings/0000918965-26-000044.md) | [776](/filings/0000918965-25-000045.md) | [747](/filings/0000918965-26-000013.md) | [705](/filings/0000918965-26-000028.md) | [813 d](/filings/0000918965-26-000044.md) | [740](/filings/0000918965-25-000045.md) | [767](/filings/0000918965-26-000013.md) | [767](/filings/0000918965-26-000028.md) | [953 d](/filings/0000918965-26-000044.md) | | Cost of revenue | $m | [770](/filings/0000918965-24-000040.md) | [784](/filings/0000918965-25-000010.md) | [658](/filings/0000918965-25-000018.md) | [649 d](/filings/0000918965-26-000044.md) | [674](/filings/0000918965-25-000045.md) | [646](/filings/0000918965-26-000013.md) | [605](/filings/0000918965-26-000028.md) | [708 d](/filings/0000918965-26-000044.md) | [632](/filings/0000918965-25-000045.md) | [664](/filings/0000918965-26-000013.md) | [660](/filings/0000918965-26-000028.md) | [833 d](/filings/0000918965-26-000044.md) | | Gross profit | $m | [107](/filings/0000918965-24-000040.md) | [101](/filings/0000918965-25-000010.md) | [94.5](/filings/0000918965-25-000018.md) | [97.3 d](/filings/0000918965-26-000044.md) | [102](/filings/0000918965-25-000045.md) | [102](/filings/0000918965-26-000013.md) | [100](/filings/0000918965-26-000028.md) | [105 d](/filings/0000918965-26-000044.md) | [107](/filings/0000918965-25-000045.md) | [103](/filings/0000918965-26-000013.md) | [107](/filings/0000918965-26-000028.md) | [120 d](/filings/0000918965-26-000044.md) | | Selling, general and administrative | $m | [75.4](/filings/0000918965-24-000040.md) | [66.9](/filings/0000918965-25-000010.md) | [66.6](/filings/0000918965-25-000018.md) | [68.5 d](/filings/0000918965-26-000044.md) | [71.7](/filings/0000918965-25-000045.md) | [73.9](/filings/0000918965-26-000013.md) | [69.7](/filings/0000918965-26-000028.md) | [71.6 d](/filings/0000918965-26-000044.md) | [75.3](/filings/0000918965-25-000045.md) | [78.1](/filings/0000918965-26-000013.md) | [78.1](/filings/0000918965-26-000028.md) | [81.7 d](/filings/0000918965-26-000044.md) | | Operating income | $m | [24.1](/filings/0000918965-24-000040.md) | [26.8](/filings/0000918965-25-000010.md) | [17.5](/filings/0000918965-25-000018.md) | [21.9 d](/filings/0000918965-26-000044.md) | [17.6](/filings/0000918965-25-000045.md) | [18.4](/filings/0000918965-26-000013.md) | [22.3](/filings/0000918965-26-000028.md) | [26.8 d](/filings/0000918965-26-000044.md) | [25.9](/filings/0000918965-25-000045.md) | [17.9](/filings/0000918965-26-000013.md) | [23.1](/filings/0000918965-26-000028.md) | [31.7 d](/filings/0000918965-26-000044.md) | | Interest expense | $m | [5.6](/filings/0000918965-23-000032.md) | [3.4](/filings/0000918965-24-000007.md) | [2.0](/filings/0000918965-24-000014.md) | [2.1 d](/filings/0000918965-26-000044.md) | [2.1](/filings/0000918965-25-000045.md) | [2.0](/filings/0000918965-26-000013.md) | [1.8](/filings/0000918965-26-000028.md) | [2.1 d](/filings/0000918965-26-000044.md) | [1.9](/filings/0000918965-25-000045.md) | [1.9](/filings/0000918965-26-000013.md) | [1.3](/filings/0000918965-26-000028.md) | [1.4 d](/filings/0000918965-26-000044.md) | | Income tax | $m | [3.7](/filings/0000918965-24-000040.md) | [7.3](/filings/0000918965-25-000010.md) | [5.1](/filings/0000918965-25-000018.md) | [6.6 d](/filings/0000918965-26-000044.md) | [6.0](/filings/0000918965-25-000045.md) | [2.7](/filings/0000918965-26-000013.md) | [6.8](/filings/0000918965-26-000028.md) | [7.4 d](/filings/0000918965-26-000044.md) | [7.1](/filings/0000918965-25-000045.md) | [2.9](/filings/0000918965-26-000013.md) | [7.2](/filings/0000918965-26-000028.md) | [7.7 d](/filings/0000918965-26-000044.md) | | Net income | $m | [15.4](/filings/0000918965-25-000018.md) | [32.7](/filings/0000918965-25-000018.md) | [12.8](/filings/0000918965-25-000018.md) | [16.1 d](/filings/0000918965-26-000044.md) | [17.0](/filings/0000918965-26-000028.md) | [17.1](/filings/0000918965-26-000028.md) | [17.4](/filings/0000918965-26-000028.md) | [20.1 d](/filings/0000918965-26-000044.md) | [19.9](/filings/0000918965-26-000028.md) | [16.5](/filings/0000918965-26-000028.md) | [16.9](/filings/0000918965-26-000028.md) | [25.6 d](/filings/0000918965-26-000044.md) | | Diluted EPS | $ per share | [0.61](/filings/0000918965-24-000040.md) | [1.29](/filings/0000918965-25-000010.md) | [0.50](/filings/0000918965-25-000018.md) | not reported | [0.69](/filings/0000918965-25-000045.md) | [0.70](/filings/0000918965-26-000013.md) | [0.74](/filings/0000918965-26-000028.md) | not reported | [0.89](/filings/0000918965-25-000045.md) | [0.75](/filings/0000918965-26-000013.md) | [0.78](/filings/0000918965-26-000028.md) | not reported | | Basic EPS | $ per share | [0.62](/filings/0000918965-24-000040.md) | [1.31](/filings/0000918965-25-000010.md) | [0.51](/filings/0000918965-25-000018.md) | not reported | [0.70](/filings/0000918965-25-000045.md) | [0.72](/filings/0000918965-26-000013.md) | [0.75](/filings/0000918965-26-000028.md) | not reported | [0.90](/filings/0000918965-25-000045.md) | [0.75](/filings/0000918965-26-000013.md) | [0.79](/filings/0000918965-26-000028.md) | not reported | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [42.6](/filings/0000918965-23-000032.md) | [45.0](/filings/0000918965-24-000007.md) | [159](/filings/0000918965-24-000014.md) | [185](/filings/0000918965-25-000029.md) | [145](/filings/0000918965-24-000040.md) | [111](/filings/0000918965-25-000010.md) | [146](/filings/0000918965-25-000018.md) | [126](/filings/0000918965-26-000044.md) | [125](/filings/0000918965-25-000045.md) | [83.5](/filings/0000918965-26-000013.md) | [120](/filings/0000918965-26-000028.md) | [88.4](/filings/0000918965-26-000044.md) | | Current assets | $m | [1,507](/filings/0000918965-23-000032.md) | [1,405](/filings/0000918965-24-000007.md) | [1,416](/filings/0000918965-24-000014.md) | [1,405](/filings/0000918965-25-000029.md) | [1,352](/filings/0000918965-24-000040.md) | [1,284](/filings/0000918965-25-000010.md) | [1,310](/filings/0000918965-25-000018.md) | [1,370](/filings/0000918965-26-000044.md) | [1,307](/filings/0000918965-25-000045.md) | [1,303](/filings/0000918965-26-000013.md) | [1,372](/filings/0000918965-26-000028.md) | [1,508](/filings/0000918965-26-000044.md) | | Total assets | $m | [1,899](/filings/0000918965-23-000032.md) | [1,781](/filings/0000918965-24-000007.md) | [1,783](/filings/0000918965-24-000014.md) | [1,779](/filings/0000918965-25-000029.md) | [1,787](/filings/0000918965-24-000040.md) | [1,703](/filings/0000918965-25-000010.md) | [1,725](/filings/0000918965-25-000018.md) | [1,786](/filings/0000918965-26-000044.md) | [1,717](/filings/0000918965-25-000045.md) | [1,742](/filings/0000918965-26-000013.md) | [1,806](/filings/0000918965-26-000028.md) | [1,932](/filings/0000918965-26-000044.md) | | Current liabilities | $m | [701](/filings/0000918965-23-000032.md) | [611](/filings/0000918965-24-000007.md) | [643](/filings/0000918965-24-000014.md) | [669](/filings/0000918965-25-000029.md) | [666](/filings/0000918965-24-000040.md) | [610](/filings/0000918965-25-000010.md) | [632](/filings/0000918965-25-000018.md) | [683](/filings/0000918965-26-000044.md) | [606](/filings/0000918965-25-000045.md) | [664](/filings/0000918965-26-000013.md) | [737](/filings/0000918965-26-000028.md) | [859](/filings/0000918965-26-000044.md) | | Total liabilities | $m | [983](/filings/0000918965-23-000032.md) | [827](/filings/0000918965-24-000007.md) | [839](/filings/0000918965-24-000014.md) | [855](/filings/0000918965-25-000029.md) | [866](/filings/0000918965-24-000040.md) | [802](/filings/0000918965-25-000010.md) | [823](/filings/0000918965-25-000018.md) | [879](/filings/0000918965-26-000044.md) | [803](/filings/0000918965-25-000045.md) | [831](/filings/0000918965-26-000013.md) | [899](/filings/0000918965-26-000028.md) | [1,022](/filings/0000918965-26-000044.md) | | Long-term debt | $m | [142](/filings/0000918965-23-000032.md) | [140](/filings/0000918965-24-000007.md) | [138](/filings/0000918965-24-000014.md) | [136](/filings/0000918965-25-000029.md) | [134](/filings/0000918965-24-000040.md) | [132](/filings/0000918965-25-000010.md) | [130](/filings/0000918965-25-000018.md) | [128](/filings/0000918965-26-000044.md) | [126](/filings/0000918965-25-000045.md) | [99.8](/filings/0000918965-26-000013.md) | [99.2](/filings/0000918965-26-000028.md) | [98.5](/filings/0000918965-26-000044.md) | | Current portion of debt | $m | [8.2](/filings/0000918965-23-000032.md) | [7.9](/filings/0000918965-24-000007.md) | [7.9](/filings/0000918965-24-000014.md) | [7.9](/filings/0000918965-25-000029.md) | [9.7](/filings/0000918965-24-000040.md) | [7.9](/filings/0000918965-25-000010.md) | [7.9](/filings/0000918965-25-000018.md) | [7.9](/filings/0000918965-26-000044.md) | [7.9](/filings/0000918965-25-000045.md) | [2.9](/filings/0000918965-26-000013.md) | [2.9](/filings/0000918965-26-000028.md) | [2.9](/filings/0000918965-26-000044.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [915](/filings/0000918965-25-000018.md) | [954](/filings/0000918965-25-000018.md) | [944](/filings/0000918965-25-000018.md) | [924](/filings/0000918965-26-000044.md) | [921](/filings/0000918965-26-000028.md) | [901](/filings/0000918965-26-000028.md) | [902](/filings/0000918965-26-000028.md) | [906](/filings/0000918965-26-000044.md) | [914](/filings/0000918965-26-000028.md) | [911](/filings/0000918965-26-000028.md) | [906](/filings/0000918965-26-000028.md) | [911](/filings/0000918965-26-000044.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [93.5](/filings/0000918965-24-000040.md) | [63.2 d](/filings/0000918965-25-000010.md) | [160 d](/filings/0000918965-25-000018.md) | [54.7 d](/filings/0000918965-26-000044.md) | [44.8](/filings/0000918965-25-000045.md) | [(6.2) d](/filings/0000918965-26-000013.md) | [66.1 d](/filings/0000918965-26-000028.md) | [7.6 d](/filings/0000918965-26-000044.md) | [23.2](/filings/0000918965-25-000045.md) | [30.8 d](/filings/0000918965-26-000013.md) | [71.4 d](/filings/0000918965-26-000028.md) | [(2.3) d](/filings/0000918965-26-000044.md) | | Capital expenditure | $m | [2.3](/filings/0000918965-24-000040.md) | [2.5](/filings/0000918965-25-000010.md) | [2.4](/filings/0000918965-25-000018.md) | [1.3 d](/filings/0000918965-26-000044.md) | [2.4](/filings/0000918965-25-000045.md) | [2.0](/filings/0000918965-26-000013.md) | [1.4](/filings/0000918965-26-000028.md) | [2.5 d](/filings/0000918965-26-000044.md) | [2.4](/filings/0000918965-25-000045.md) | [2.0](/filings/0000918965-26-000013.md) | [2.4](/filings/0000918965-26-000028.md) | [2.5 d](/filings/0000918965-26-000044.md) | | Share repurchases | $m | [0.0](/filings/0000918965-24-000040.md) | [1.3 d](/filings/0000918965-25-000010.md) | [19.9 d](/filings/0000918965-25-000018.md) | [21.7 d](/filings/0000918965-26-000044.md) | [28.1](/filings/0000918965-25-000045.md) | [24.2 d](/filings/0000918965-26-000013.md) | [28.9 d](/filings/0000918965-26-000028.md) | [25.3 d](/filings/0000918965-26-000044.md) | [21.3](/filings/0000918965-25-000045.md) | [17.4 d](/filings/0000918965-26-000013.md) | [32.7 d](/filings/0000918965-26-000028.md) | [26.5 d](/filings/0000918965-26-000044.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [25.5](/filings/0000918965-23-000032.md) | [25.5](/filings/0000918965-24-000007.md) | [25.4](/filings/0000918965-24-000014.md) | [25.2](/filings/0000918965-24-000040.md) | [25.3](/filings/0000918965-25-000010.md) | [25.4](/filings/0000918965-25-000018.md) | [24.6](/filings/0000918965-25-000045.md) | [24.2](/filings/0000918965-26-000013.md) | [23.6](/filings/0000918965-26-000028.md) | [22.4](/filings/0000918965-25-000045.md) | [22.1](/filings/0000918965-26-000013.md) | [21.6](/filings/0000918965-26-000028.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 20,142,812 at 2026-08-17, from the cover of the [10-K filed 2026-08-20](/filings/0000918965-26-000044.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.